Induction of antigen-specific cytolytic T cells in situ in human melanoma by immunization with synthetic peptide-pulsed autologous antigen presenting cells.
…, T Okino, H Yamase, JR Sporn… - Proceedings of the …, 1995 - National Acad Sciences
Human melanoma cells can process the MAGE-1 gene product and present the processed
nonapeptide EADPTGHSY on their major histocompatibility complex class I molecules, HLA-…
nonapeptide EADPTGHSY on their major histocompatibility complex class I molecules, HLA-…
Immunization with a tumor-cell-lysate-loaded autologous-antigen-presenting-cell-based vaccine in melanoma
NG Chakraborty, JR Sporn, AF Tortora… - Cancer Immunology …, 1998 - Springer
The discoveries of human melanoma-associated antigens in molecular terms have renewed
interest in peptide- or peptide- and antigen-presenting-cell (APC)-based cancer vaccines. …
interest in peptide- or peptide- and antigen-presenting-cell (APC)-based cancer vaccines. …
Presynaptic modulation of beta adrenergic receptors in rat cerebral cortex after treatment with antidepressants.
BB Wolfe, TK Harden, JR Sporn, PB Molinoff - Journal of Pharmacology and …, 1978 - ASPET
Treatment with desmethylimipramine (DMI), a tricyclic antidepressant, for 7 to 21 days resulted
in a 35 to 45% decrease in the accumulation of adenosine cyclic 3':5'-monophosphate (…
in a 35 to 45% decrease in the accumulation of adenosine cyclic 3':5'-monophosphate (…
Enhancement of cytolytic T lymphocyte precursor frequency in melanoma patients following immunization with the MAGE-1 peptide loaded antigen presenting cell …
X Hu, NG Chakraborty, JR Sporn, SH Kurtzman… - Cancer research, 1996 - AACR
Identification of human melanoma-associated peptide antigens for CTLs has opened
unprecedented opportunities for active specific immunotherapy for melanoma with synthetic peptide…
unprecedented opportunities for active specific immunotherapy for melanoma with synthetic peptide…
β-Adrenergic receptor involvement in 6-hydroxydopamine-induced supersensitivity in rat cerebral cortex
JR Sporn, TK Harden, BB Wolfe, PB Molinoff - Science, 1976 - science.org
The intraventricular administration of 6-hydroxydopamine, a procedure which destroys
noradrenergic nerve terminals in the central nervous system, caused an increase in the density of …
noradrenergic nerve terminals in the central nervous system, caused an increase in the density of …
Ontogeny of β-adrenergic receptors in rat cerebral cortex
TK Harden, BB Wolfe, JR Sporn, JP Perkins… - Brain Research, 1977 - Elsevier
The ontogeny of β-adrenergic receptors in rat cerebral cortex has been studied using [ 125 I]iodohydroxyzylpindolol
as a ligand in an in vitro binding assay. The concentration of β-…
as a ligand in an in vitro binding assay. The concentration of β-…
Recognition of PSA-derived peptide antigens by T cells from prostate cancer patients without any prior stimulation
…, S Mehrotra, E Laska, P Taxel, JR Sporn… - Cancer Immunology …, 2003 - Springer
Prostate-specific antigen (PSA) is a valuable marker antigen for prostate cancer. Lately
considerable interest has been generated in the prospect of developing a vaccine for prostate …
considerable interest has been generated in the prospect of developing a vaccine for prostate …
Supersensitivity in rat cerebral cortex: pre-and postsynaptic effects of 6-hydroxydopamine at noradrenergic synapses
JR SPORN, BB WOLFE, TK HARDEN… - Molecular …, 1977 - ASPET
The intraventricular administration of 6-hydroxydopamine resulted in the destruction of
noradrenergic nerve terminals in the rat cerebral cortex and a 90% decrease in norepinephrine …
noradrenergic nerve terminals in the rat cerebral cortex and a 90% decrease in norepinephrine …
Emergence of regulatory CD4+ T cell response to repetitive stimulation with antigen-presenting cells in vitro: implications in designing antigen-presenting cell-based …
NG Chakraborty, L Li, JR Sporn… - The Journal of …, 1999 - journals.aai.org
Because APCs play a crucial role in the generation of T cell-mediated immune responses,
numerous clinical trials with APC-based vaccines have been initiated in different types of …
numerous clinical trials with APC-based vaccines have been initiated in different types of …
Empiric chemotherapy in patients with carcinoma of unknown primary site
JR Sporn, BR Greenberg - The American journal of medicine, 1990 - Elsevier
… Requests for reprints should be addressed to Jonathan R. Sporn, MD, Division of
Hematology-Oncology, University of Connecticut Health Center, Farmington, Connecticut 06032. …
Hematology-Oncology, University of Connecticut Health Center, Farmington, Connecticut 06032. …